1. Clinical and MRI phenotypes of sarcoidosis-associated myelopathy. Issue 4 (July 2020) Authors: Murphy, Olwen C.; Salazar-Camelo, Andrea; Jimenez, Jorge A.; Barreras, Paula; Reyes, Maria I.; Garcia, Maria A.; Moller, David R.; Chen, Edward S.; Pardo, Carlos A. Journal: Neurology Issue: Volume 7:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune mechanisms in fibrotic pulmonary sarcoidosis. (21st December 2022) Authors: Weeratunga, Praveen; Moller, David R.; Ho, Ling-Pei Journal: European respiratory review Issue: Volume 31:Number 166(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents. (2019) Authors: Sharp, Michelle; Donnelly, Seamas C.; Moller, David R. Journal: Respiratory medicine Issue: Volume 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗